Access to and appropriate use of safe, effective, quality-assured, and affordable medicines and pharmaceutical services.
The USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program is dedicated to enhancing public health outcomes through improved access to and appropriate use of safe, effective, quality-assured, and affordable medicines and pharmaceutical services. Operating with a commitment to strengthening pharmaceutical systems, the MTaPS program works tirelessly to support health system performance and advance critical healthcare objectives on a global scale.
MTaPS focuses on several key objectives, including strengthening pharmaceutical-sector governance, increasing institutional and human resource capacity for pharmaceutical management and services, advancing the availability and use of pharmaceutical information for decision-making, optimizing pharmaceutical-sector financing, and improving pharmaceutical services to achieve desired health outcomes. Through a comprehensive approach, the program strives to ensure sustainable access to essential medicines, vaccines, and other health technologies.
The USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program continues to make significant strides in the public health sector. To further explore opportunities for collaboration and customized solutions, we invite the program's management team to create a customized and exclusive company showcase and product listing on our platform.
Other organizations in the same industry
This company is also known as